Abstract
THE induction of monoclonal, plasma cell tumours which produce immunoglobulin in the inbred BALB/c strain of mice is a unique form of carcinogenesis1,2. Mouse plasma cell tumours have been produced by intraperitoneal implantation of solid materials, such as plastic diffusion chambers, polymethylmethacrylate plastic shavings3,4 and circular disks4, and by intraperitoneal injection of various high and low viscosity white mineral oils1,2,5. White mineral oils comprise a poorly defined mixture of saturated hydrocarbons, including normal and iso-paraffins, and naphthenes6, and such oils contain many hundreds of different molecular species (C. Steenbergen, personal communication). Because of the chemical heterogeneity of the oils used, it has been impossible to identify or trace the particular chemical species involved in plasma cell tumour induction. Since the discovery that the immunoglobulin products of some human Waldenström macroglobulinaemias7, multiple myelomas8 and some mouse plasma cell tumours2,9,10 exhibit antibody activity, it has become important to elucidate more fully the factors involved in the carcinogenesis of the murine plasma cell tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Potter, M., Methods in Cancer Res., 2, 105 (1967).
Cohn, M., Cold Spring Harbor Symp. Quant. Biol., 32, 211 (1967).
Merwin, R. M., and Algire, G. H., Proc. Soc. Exp. Biol. and Med., 101, 437 (1959).
Merwin, R. M., and Redmon, L. W., J. Nat. Cancer Inst., 31, 997 (1963).
Potter, M., and Boyce, C. R., Nature, 193, 1086 (1962).
Fiero, G. W., Ann. Allergy, 23, 226 (1965).
Stone, M. J., and Metzger, H., Cold Spring Harbor Symp. Quant. Biol., 32, 83 (1967).
Eisen, H. N., Little, J. R., Osterland, C. K., and Simms, E. S., Cold Spring Harbor Symp. Quant. Biol., 32, 75 (1967).
Potter, M., and Leon, M. A., Science, 162, 369 (1968).
Schubert, D., Jobe, A., and Cohn, M., Nature, 220, 882 (1968).
Wilner, B. I., Evers, M. A., Troutman, H. D., Trader, F. W., and McLean, jun., I. W., J. Immunol., 91, 210 (1963).
Potter, M., and MacCardle, R. C., J. Nat. Cancer Inst., 33, 497 (1964).
Madison, R. M., Rabstein, L. W., and Bryan, W. R., J. Nat. Cancer Inst., 40, 683 (1968).
Boitnott, J. K., and Margolis, S., Fed. Proc., 25, 200 (66) (1966).
Boitnott, J. K., and Margolis, S., Bull. Johns Hopkins Hosp., 118, 402, 414 (1966).
Avigan, J., Milne, G. W. A., and Highet, R. J., Biochim. Biophys. Acta 144, 127 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ANDERSON, P., POTTER, M. Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane). Nature 222, 994–995 (1969). https://doi.org/10.1038/222994a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/222994a0
This article is cited by
-
The genetic landscape of 5T models for multiple myeloma
Scientific Reports (2018)
-
KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice
Blood Cancer Journal (2016)
-
Differential development of oil granulomas induced by pristane injection in galectin-3 deficient mice
BMC Immunology (2015)
-
Adjuvants and lymphoma risk as part of the ASIA spectrum
Immunologic Research (2015)
-
Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
Immunologic Research (2014)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.